Cargando…
Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas
PURPOSE: Adenocarcinomas of the esophagus (AEG) and stomach (AS) are among the most common cancers worldwide. Novel markers for risk stratification and guiding treatment are strongly needed. Activin is a multi-functional cytokine with context specific pro- and anti-tumorigenic effects. We aimed to i...
Autores principales: | Staudacher, J. J., Arnold, Alexander, Kühl, A. A., Pötzsch, M., Daum, S., Winterfeld, M., Berg, E., Hummel, M., Rau, B., Stein, U., Treese, C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446826/ https://www.ncbi.nlm.nih.gov/pubmed/36064338 http://dx.doi.org/10.1186/s12885-022-10016-5 |
Ejemplares similares
-
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
por: Arnold, A., et al.
Publicado: (2020) -
Better prognosis of gastric cancer patients with high levels of tumor infiltrating lymphocytes is counteracted by PD-1 expression
por: Pötzsch, M., et al.
Publicado: (2020) -
Inhibition of MACC1-Induced Metastasis in Esophageal and Gastric Adenocarcinomas
por: Treese, Christoph, et al.
Publicado: (2022) -
S100A4 Is a Strong Negative Prognostic Marker and Potential Therapeutic Target in Adenocarcinoma of the Stomach and Esophagus
por: Treese, Christoph, et al.
Publicado: (2022) -
Evidence of inhibin/activin subunit betaC and betaE synthesis in normal human endometrial tissue
por: Mylonas, Ioannis, et al.
Publicado: (2010)